A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

Clinical trial NCT07356453 · RECRUITING

Trial details

NCT number: NCT07356453
Sponsor: FoRx Therapeutics AG
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-07-22
Primary completion: 2027-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.